CN101978043A - 产生可用作抗癌药的蒽环类代谢物的遗传修饰菌株 - Google Patents
产生可用作抗癌药的蒽环类代谢物的遗传修饰菌株 Download PDFInfo
- Publication number
- CN101978043A CN101978043A CN200880015212XA CN200880015212A CN101978043A CN 101978043 A CN101978043 A CN 101978043A CN 200880015212X A CN200880015212X A CN 200880015212XA CN 200880015212 A CN200880015212 A CN 200880015212A CN 101978043 A CN101978043 A CN 101978043A
- Authority
- CN
- China
- Prior art keywords
- bacterial strain
- daunorubicin
- daunomycin
- rhodomycinon
- metabolite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
- C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
菌株 | 4′-表道诺红菌素 | 13-DHED | 4′-表领地霉素B | 其他表道诺霉素类化合物(未具体指明)* | ε-紫红霉酮 |
G001/pB70dv | 250-350 | 50-150 | 无 | 350-450 | 200-300 |
含有pB89rdmB的克隆 | 350-450 | 250-400 | 150-250 | <100 | 150-300 |
经NTG诱变处理菌株 | 500-700 | 400-600 | 150-300 | <100 | 150-300 |
菌株/质粒 | 说明 | 参考文献或来源 |
大肠杆菌XL1-Blue | 大肠杆菌克隆用宿主 | Stratagene |
G001 | 产生道诺霉素的链霉菌菌株 | DSM12245 |
G001/pB70dv | 产生表道诺霉素类化合物和表洋红霉素的链霉菌菌株 | DSM 19076 |
时间(分钟) | 溶剂A[%] | 溶剂B[%] |
0 | 80 | 20 |
10 | 60 | 40 |
27 | 45 | 55 |
28 | 10 | 90 |
30 | 10 | 90 |
31 | 80 | 20 |
36 | 80 | 20 |
Claims (19)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07009217.6 | 2007-05-08 | ||
EP07009217.6A EP1990405B1 (en) | 2007-05-08 | 2007-05-08 | Genetically modified strains producing anthracycline metabolites useful as cancer drugs |
PCT/EP2008/003447 WO2008135195A1 (en) | 2007-05-08 | 2008-04-29 | Genetically modified strains producing anthracycline metabolites useful as cancer drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101978043A true CN101978043A (zh) | 2011-02-16 |
CN101978043B CN101978043B (zh) | 2013-06-19 |
Family
ID=38387557
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880015212XA Active CN101978043B (zh) | 2007-05-08 | 2008-04-29 | 产生可用作抗癌药的蒽环类代谢物的遗传修饰菌株 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20100143977A1 (zh) |
EP (1) | EP1990405B1 (zh) |
JP (1) | JP2010525828A (zh) |
KR (1) | KR101177175B1 (zh) |
CN (1) | CN101978043B (zh) |
CA (1) | CA2687034A1 (zh) |
DK (1) | DK1990405T3 (zh) |
ES (1) | ES2644422T3 (zh) |
MX (1) | MX2009012029A (zh) |
PL (1) | PL1990405T3 (zh) |
TW (1) | TWI374187B (zh) |
WO (1) | WO2008135195A1 (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106459124A (zh) * | 2014-04-30 | 2017-02-22 | 尼德制药股份有限公司 | 表柔红霉素的纯化 |
CN107541481A (zh) * | 2016-06-23 | 2018-01-05 | 上海医药工业研究院 | 一种产表阿霉素的基因工程菌及其应用 |
CN107683284A (zh) * | 2015-03-30 | 2018-02-09 | 明治制果药业株式会社 | 表柔比星的制造方法及其新的制造中间体 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2636676A3 (en) | 2009-09-08 | 2014-01-01 | Heraeus Precious Metals GmbH & Co. KG | Crystallization of epidaunorubicin x HCl |
DE102011103751A1 (de) | 2011-05-31 | 2012-12-06 | Heraeus Precious Metals Gmbh & Co. Kg | Kristallisierung von Epirubicinhydrochlorid |
DE102011111991A1 (de) * | 2011-08-30 | 2013-02-28 | Lead Discovery Center Gmbh | Neue Cyclosporin-Derivate |
CN105861455B (zh) * | 2016-05-16 | 2018-10-26 | 浙江海正药业股份有限公司 | DoxA蛋白突变体及其编码基因与应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3060472D1 (en) | 1979-09-01 | 1982-07-15 | Erba Farmitalia | Anthracycline glycosides, processes for their preparation and pharmaceutical composition containing them |
ATE195526T1 (de) | 1996-12-16 | 2000-09-15 | Pharmachemie Bv | Verfahren zur herstellung von epirubicin oder zusatzsalzen davon, von daunorubicin |
US5955319A (en) | 1997-07-28 | 1999-09-21 | Pharmacia & Upjohn, S.P.A. | Process for preparing doxorubicin |
US6210930B1 (en) | 1997-03-06 | 2001-04-03 | Pharmacia & Upjohn, S.P.A. | Process for preparing doxorubicin |
US20020012979A1 (en) * | 1998-06-08 | 2002-01-31 | Alan Berry | Vitamin c production in microorganisms and plants |
FI107053B (fi) | 1998-10-23 | 2001-05-31 | Galilaeus Oy | Nogalamysiinin biosynteesiin liittyvä geeniryhmittymä ja sen käyttö hybridiantibioottien tuotossa |
DE10300719A1 (de) * | 2003-01-11 | 2004-07-22 | Basf Ag | Verbessertes Verfahren zur Herstellung von Vitamin B12 |
WO2006111561A1 (en) | 2005-04-21 | 2006-10-26 | Dsm Ip Assets B.V. | Improved microbial production of anthracyclins |
-
2007
- 2007-05-08 ES ES07009217.6T patent/ES2644422T3/es active Active
- 2007-05-08 DK DK07009217.6T patent/DK1990405T3/da active
- 2007-05-08 PL PL07009217T patent/PL1990405T3/pl unknown
- 2007-05-08 EP EP07009217.6A patent/EP1990405B1/en active Active
-
2008
- 2008-04-29 CA CA002687034A patent/CA2687034A1/en not_active Abandoned
- 2008-04-29 CN CN200880015212XA patent/CN101978043B/zh active Active
- 2008-04-29 US US12/598,806 patent/US20100143977A1/en not_active Abandoned
- 2008-04-29 MX MX2009012029A patent/MX2009012029A/es active IP Right Grant
- 2008-04-29 WO PCT/EP2008/003447 patent/WO2008135195A1/en active Application Filing
- 2008-04-29 KR KR1020097023289A patent/KR101177175B1/ko active IP Right Grant
- 2008-04-29 JP JP2010506832A patent/JP2010525828A/ja active Pending
- 2008-09-25 TW TW097136944A patent/TWI374187B/zh active
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106459124A (zh) * | 2014-04-30 | 2017-02-22 | 尼德制药股份有限公司 | 表柔红霉素的纯化 |
CN106459124B (zh) * | 2014-04-30 | 2019-11-12 | 尼德制药股份有限公司 | 表柔红霉素的纯化 |
CN107683284A (zh) * | 2015-03-30 | 2018-02-09 | 明治制果药业株式会社 | 表柔比星的制造方法及其新的制造中间体 |
CN107541481A (zh) * | 2016-06-23 | 2018-01-05 | 上海医药工业研究院 | 一种产表阿霉素的基因工程菌及其应用 |
CN107541481B (zh) * | 2016-06-23 | 2021-07-02 | 上海医药工业研究院 | 一种产表阿霉素的基因工程菌及其应用 |
Also Published As
Publication number | Publication date |
---|---|
JP2010525828A (ja) | 2010-07-29 |
WO2008135195A1 (en) | 2008-11-13 |
EP1990405B1 (en) | 2017-07-26 |
ES2644422T3 (es) | 2017-11-28 |
MX2009012029A (es) | 2010-01-25 |
US20100143977A1 (en) | 2010-06-10 |
KR101177175B1 (ko) | 2012-08-24 |
DK1990405T3 (da) | 2017-11-06 |
CN101978043B (zh) | 2013-06-19 |
EP1990405A1 (en) | 2008-11-12 |
CA2687034A1 (en) | 2008-11-13 |
TW201012923A (en) | 2010-04-01 |
KR20100010503A (ko) | 2010-02-01 |
PL1990405T3 (pl) | 2018-01-31 |
TWI374187B (en) | 2012-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101978043B (zh) | 产生可用作抗癌药的蒽环类代谢物的遗传修饰菌株 | |
Ren et al. | Enhancement of nystatin production by redirecting precursor fluxes after disruption of the tetramycin gene from Streptomyces ahygroscopicus | |
US9505779B2 (en) | Tacrolimus analogues, a neuroprotective composition comprising the same, an immunosuppressive composition comprising the same, a method for preparing the same, and a mutant for producing the same | |
JP6882330B2 (ja) | カリマイシン(Carrimycin)生合成遺伝子クラスタ | |
CN110218244A (zh) | 化合物ilamycin F及其应用 | |
Gu et al. | Effects of chromosomal integration of the Vitreoscilla Hemoglobin Gene (vgb) and S-Adenosylmethionine synthetase gene (metK) on ε-Poly-l-Lysine synthesis in Streptomyces albulus NK660 | |
CN101802168A (zh) | 非天然型抗生素的制造方法 | |
EP2042608B1 (en) | Genetically modified Streptomyces strains for biotransformations in anthracycline production | |
WO2001012643A1 (fr) | Caprazamycines antibiotiques et leur procede de production | |
CA2252725C (en) | A process for the biotransformation of colchicinoid compounds into the corresponding 3-glycosyl derivatives | |
CN102906258A (zh) | 酮还原酶突变体 | |
AU2008361598B2 (en) | Genetically modified strains for biotransformations in anthracycline production | |
CN100393867C (zh) | 格尔德霉素基因工程高产菌株的构建 | |
Tatsuno et al. | Extensive mutational analysis of modular-iterative mixed polyketide biosynthesis of lankacidin in Streptomyces rochei | |
CN107541535B (zh) | 发酵培养基及生产表阿霉素的方法 | |
CA2354030A1 (en) | Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto | |
CN108864221B (zh) | 阿克拉霉素类似物及其制法和用途 | |
CN108456689A (zh) | 提高安丝菌素p-3生物合成产量的方法 | |
JP4759756B2 (ja) | 抗生物質カプラザマイシンd、g、d1、g1とその製造法 | |
EP0792285B1 (en) | Process for producing anthracyclines and intermediates thereof | |
CN116426454A (zh) | 一种提高阿维菌素B1a组分效价和比例的基因工程方法 | |
CN114875095A (zh) | 一种丙氨酰美登醇及其合成方法和应用 | |
WO2001023578A9 (en) | The gene cluster involved in aclacinomycin biosynthesis, and its use for genetic engineering | |
CN101812103B (zh) | 基因工程改造六-甲基水杨酸合成酶并组合生物合成螺环乙酰乙酸内酯类抗生素 | |
WO2004057011A1 (ja) | 抗生物質カプラザマイシンd、g、d1およびg1とその製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: HERAEUS PRECIOUS METALS GMBH + CO. KG Free format text: FORMER OWNER: HERAEUS MATERIALS TECHNOLOGY GMBH + CO. KG Effective date: 20120815 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Hanau, Germany Applicant after: HERAEUS MATERIALS TECHNOLOGY GmbH & Co.KG Address before: Hanau, Germany Applicant before: W.C. HERAEUS GmbH |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: W.C. HERAEUS GMBH TO: HERAEUS MATERIALS TECHNOLOGY GMBH + CO. KG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120815 Address after: Hanau, Germany Applicant after: Heraeus Precious Metals GmbH & Co.KG Address before: Hanau, Germany Applicant before: HERAEUS MATERIALS TECHNOLOGY GmbH & Co.KG |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160302 Address after: Finland Patentee after: Universal International Inc. Address before: Hanau, Germany Patentee before: Heraeus Precious Metals GmbH & Co.KG |